The Hardman & Co Healthcare Index (HHI) has been running since 2009. Its main function is to highlight the attractions of life sciences investments over the long term. For the second year running, apart from global economic influences affecting world markets, performance in 2023 was dented by the capital-intensive nature of the sector. The HHI fell 3.7%, to 483.8, underperforming the main London markets – FTSE 100 (+3.8%) and FTSE All-Share (3.8%) but outperforming the FTSE AIM All-Share Index (...
A director at Indiva Ltd bought 639,000 shares at 0.050CAD and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked....
Fundamental Research Corp has issued a report entitled “Indiva Limited (TSXV: NDVA / OTCQX: NVDAF) Wana Gummies Start Strong; Expecting Record Q4 – FINAL REPORT” and dated December 8, 2020. The full report is now at NDVA is being removed as an FRC Top Pick
Fundamental Research Corp has issued a report entitled “Indiva Limited (TSXV: NDVA / OTCQX: NVDAF) Q2-2020 Revenue up 27% QoQ with Enhanced Offerings” and dated September 14, 2020. The full report is now at Indiva is an FRC Top Pick
Fundamental Research Corp has issued a report entitled “Indiva Limited (TSXV: NDVA / OTCQX: NVDAF) Q1-2020 Revenue up 734% YoY and 522% QoQ†and dated June 16, 2020. The full report is now at NDVA is an FRC Top Pick *FRC provides issuer paid coverage
Fundamental Research Corp has issued a report entitled “Indiva Limited (TSXV: NDVA / OTCQX: NVDAF) 2019 Revenues Ahead of Expectations; Expected to Increase Significantly in 2020†and dated May 21, 2020. The full report is now at NDVA is an FRC Top Pick *FRC provides issuer paid coverage; read all the important disclosures at the back of each report
Fundamental Research Corp has issued a report entitled “Indiva Limited (TSXV: NDVA / OTCQX: NDVAF) Portfolio of Award-Winning Cannabis Brands to Target Cannabis 2.0 – Initiating Coverage†and dated April 8, 2020. The full report is now at NDVA is an FRC Top Pick Key Highlights Investment Highlights  Indiva Ltd. (“Indivaâ€, “companyâ€) operates a 40,000 sq. ft. facility (“Indiva facilityâ€) in Ontario and is involved in the manufacture and sale of pre-rolls and pouches, awa...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.